The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin.
about
Endoscopic botox injections in therapy of refractory gastroparesisEvaluation and management of dyspepsia.Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meetingClinical guideline: management of gastroparesisTreatment of patients with diabetic gastroparesis.Gastroparesis: current diagnostic challenges and management considerationsManagement of diabetic gastroparesis.Diabetic gastroparesis: Therapeutic options.The hungry stomach: physiology, disease, and drug development opportunities.Treatments of medical complications of anorexia nervosa and bulimia nervosa.Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptyingProkinetics in the Management of Functional Gastrointestinal Disorders.Treatment options for patients with severe gastroparesisEarly investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials.Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists.The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying.Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus.Synchronized gastric electrical stimulation improves vagotomy-induced impairment in gastric accommodation via the nitrergic pathway in dogsNovel Diet, Drugs, and Gastric Interventions for Gastroparesis.Evaluation of prokinetic agents used in the treatment of gastroparesis.Gastric Function in Children with Oesophageal Atresia and Tracheoesophageal FistulaGastroparesis Updates on Pathogenesis and Management.Case report--the 46 year old man with a 5 month history of vomiting.Cefaclor, a cephalosporin antibiotic, delays gastric emptying rate by a CCK-A receptor-mediated mechanism in the rat.The effect of erythromycin on gastrointestinal motility in subtotal gastrectomized patients.Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro.Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.Relationship Between Gastric Emptying and Diurnal Glycemic Control in Type 1 Diabetes Mellitus: A Randomized Trial.Diabetic gastroparesis: current challenges and future prospects
P2860
Q26801922-9C58D62D-F2C5-477B-AE26-126606831818Q30433839-02C07A71-233D-4C0B-82AB-4D8759D2B5D3Q33941371-8C5133ED-40D0-43DE-AAEF-424D3612F493Q34034345-F0F032C4-1E9A-4442-A465-EAAA8AAAD2B1Q34062045-D4713D1A-1E88-4B12-A951-A85C4D826BADQ34602527-65E9C833-04ED-4A3F-AA10-AA572AF6F5FDQ34996050-6321EB9D-BE9B-4AD5-AB6B-B2E640CB4BE6Q35054446-188AB047-700E-4F24-8A26-8F432068B143Q35215647-2B335828-E040-474C-A350-EF6E5DE9BF52Q35410029-F1735290-9730-441F-BF27-23C44A5F4880Q35597269-CA0E6472-C273-4558-9D89-188C2C4E31D0Q35834499-52A85153-E450-4020-AB3B-A2A3BF0A3E68Q35953930-3AAD2F3C-A63B-47A1-8637-347D9EC7416AQ36082843-4A81609F-DB18-4887-8B41-35F6F07674CFQ36619744-C41BF59F-3BED-4E33-9B7E-154A2F0DAD44Q36903406-0480A5CF-7307-4A29-8A5E-23FEE75743AFQ37056852-FA6487F0-E230-46E3-B1F6-4187A0E8F888Q37100273-B8D5B0E1-CFD2-4AFB-AA3B-AA6283E3BA62Q38695314-4F7F0D90-65DF-4979-B4D0-48ECB95A22A6Q39164792-8E551274-E531-4AF5-8C7E-382A29FA78E0Q39265755-C688BEB6-9783-4CF4-A8C5-1EDD14513A40Q39324779-A8A3D165-31E4-471F-AFD5-6FE1D6E23D4BQ39878921-627D8DE2-989A-4FCF-A075-2C42FFC1AF3EQ41860092-8BC4D4DA-8100-442A-9372-36EAE2B1F42DQ41903191-18A4C588-DB81-4270-A527-D4228B5147CFQ41952109-935C643E-EC78-472A-871D-AE4BBA36398EQ47816254-215A7FAF-0157-4C40-8FD3-8C4631CD5986Q48034787-8C26742A-6FA9-4063-B80E-7D1D801A4225Q57491893-2146C068-C396-499F-B1D5-382E1A104E1E
P2860
The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin.
description
1993 nî lūn-bûn
@nan
1993 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
The treatment of idiopathic an ...... and chronic oral erythromycin.
@ast
The treatment of idiopathic an ...... and chronic oral erythromycin.
@en
type
label
The treatment of idiopathic an ...... and chronic oral erythromycin.
@ast
The treatment of idiopathic an ...... and chronic oral erythromycin.
@en
prefLabel
The treatment of idiopathic an ...... and chronic oral erythromycin.
@ast
The treatment of idiopathic an ...... and chronic oral erythromycin.
@en
P2093
P1476
The treatment of idiopathic an ...... and chronic oral erythromycin
@en
P2093
Davenport K
McCallum RW
Richards RD
P304
P407
P577
1993-02-01T00:00:00Z